Boston Therapeutics, Inc. Note Agreements
13 Contracts & Agreements
- Form of Senior Secured Convertible Note, dated February 28, 2022 (Filed With SEC on March 1, 2022)
- Form of Senior Secured Convertible Note, dated June 25, 2021 (Filed With SEC on June 29, 2021)
- Form of Promissory Note dated April 30, 2021 (Filed With SEC on May 12, 2021)
- Form of 10% Promissory Note issued by Nanomix, Inc. to Boston Therapeutics Inc (Filed With SEC on May 12, 2021)
- Form of Promissory Note dated June 12, 2018 (Filed With SEC on June 14, 2018)
- Form of 10% Convertible Promissory Note issued to CJY Holdings Limited (Filed With SEC on October 2, 2015)
- Convertible Promissory Note between Boston Therapeutics, Inc. and JDF Capital, Inc. dated as of March 13, 2015 (Filed With SEC on May 20, 2015)
- Convertible Note between Boston Therapeutics, Inc. and JMJ Financial dated as of March 18, 2015 (Filed With SEC on May 20, 2015)
- Convertible Promissory Note between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated as of March 16, 2015 (Filed With SEC on May 20, 2015)
- Convertible Promissory Note between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015 (Filed With SEC on May 20, 2015)
- Promissory Note dated as of February 9, 2010 issued by the Company to David Platt (Filed With SEC on November 14, 2013)
- Promissory Note dated as of February 9, 2010 issued by the Company to David Platt (Filed With SEC on September 21, 2012)
- PROMISSORY NOTE $78,820.28Made as of February 9, 2010 (Filed With SEC on June 24, 2010)
